Propafenone Fatality: A Case Report Illustrated with Blood Concentration Data [5];Intoxication Fatale par la Propafénone: À Propos d'un Cas Documenté par des Dosages Sanguins

Therapie

Volumn 58, Issue 4, 2003, Pages 384-386

  Palette, Catherine ^a   Maroun, Nadine ^a   Gaulier, Jean Michel ^b   Priolet, Bruno ^a   Lachatre, Gérard ^b   Bedos, Jean Pierre ^a   Advenier, Charles ^a   Thérond, Patrice ^a  

^a CENTRE HOSPITALIER DE VERSAILLES   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Intoxications; Metabolites; Plasma assay; Propafenone

Indexed keywords

CLONAZEPAM; PROPAFENONE;

CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG METABOLISM; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; INTOXICATION; LETTER; PRIORITY JOURNAL;

EID: 0344873742     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie:2003062     Document Type: Letter

References (22)

1. ème édition. Paris: Expansion scientifique française, 1988: 458-502
2. Connolly SJ, Kates RE, Lebsack CS, et al. Clinical pharmacology of propafenone. Circulation 1983; 68: 589-96
3. Coumel P, Leclercq JF, Assayag P. European experience with the anti-arrhythmic efficacy of propafenone for supraventricular and ventricular arrythmias. Am J Cardiol 1984; 54: 60D-6D
4. Funck-Brentano C, Kroemer HK, Lee JT, et al. Propafenone. N Engl J Med 1990; 322: 518-25
5. von Philipsborn G, Gries J, Hofmann HP, et al. Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone. Arzneimittel Forschung 1984; 34: 1489-97
6. Siddoway LA, Thompson KA, McAllister CB, et al. Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences. Circulation 1987; 75: 785-91
7. Capucci A, Boriani G, Marchesini B, et al. Minimal effective concentration values of propafenone and 5-hydroxy-propafenone in acute and chronic therapy. Cardiovasc Drugs Ther 1990; 4: 281-7
8. Kates RE, Yee YG, Winkle RA. Metabolite cumulation during chronic propafenone dosing in arrhythmia. Clin Pharmacol Ther 1985: 37 (6): 610-4
9. Hii JT, Duff HJ, Burgess ED. Clinical pharmacokinetics of propafenone. Clin Pharmacokinet 1991; 21: 1-10
10. Anzenbacherova E, Anzenbacher P, Perlik F, et al. Use of a propafenone metabolic ratio as a measure of CYP2D6 activity. Int J Clin Pharmacol Ther 2000; 38: 426-9
11. Vozeh S, Haefeli W, Ha HR, et al. Nonlinear kinetics of propafenone metabolites in healthy man. Eur J Clin Pharmacol 1990; 38: 509-13
12. Dilger K, Hofmann U, Klotz U. Enzyme induction in the elderly: effect of rifampin on the pharmacokinetics and pharmacodynamics of propafenone. Clin Pharmacol Ther 2000; 67: 512-20
13. Kroemer HK, Botsch S, Heinkele G, et al. In vitro assessment of various cytochromes P450 and glucuronosyltransferases using the antiarrhythmic propafenone as a probe drug. Methods Enzymol 1996; 272: 99-105
14. Lanquetot H, Furet Y, Kerourédan V, et al. Intoxication mortelle par association propafénone-amitriptylline: à propos d'un cas. Agressologie 1988; 29: 39-42
15. Maxeiner H, Klug E. Lethal suicidal intoxication with propafenone, after a history of self-inflicted injuries. Forensic Sci Int 1997; 89: 27-32
16. Kunicki PK, Paczkowski D, Sitkiewicz D. High-performance liquid chromatographic method for the simultaneous determination of propafenone and 5-hydroxypropafenone in human serum. Pol J Pharmacol Pharm 1992; 44: 161-71
17. Fonck K, Haenebalcke C, Hemeryck A, et al. ECG changes and plasma concentrations of propafenone and its metabolites in a case of severe poisoning. J Toxicol Clin Toxicol 1998; 36: 247-51
18. Friocourt P, Martin C, Lozac'h A. Intoxication volontaire par la propafénone: à propos d'un cas. Ann Cardiol Angeiol (Paris) 1988; 37: 133-6
19. Köppel C, Oberdisse U, Heinemeyer G. Clinical course and outcome in class IC anti-arrhythmic overdose. J Toxicol Clin Toxicol 1990; 28: 433-44
20. Kerns W, English B, Ford M. Propafenone overdose. Ann Emerg Med 1994; 24: 98-103
21. Picciotto G, Siragusa V, Cellura M, et al. Intossicazione acuta da propafenone: descrizione di un caso. Minerva Cardioangiol 1990; 38: 555-8
22. Hollmann M, Brode E, Holtz D, et al. Investigations on the pharmacokinetics of propafenone in man. Arzneimittel Forschung 1983; 33: 763-70